"What" Series

What information about clinical studies can be found in the ClinicalTrials.gov database?

22 January 2024
2 min read

The ClinicalTrials.gov database provides information about clinical trials that are currently recruiting or have recently been completed. It includes a variety of trial types, such as interventional, observational, prevention, treatment, diagnostic, device, behavioral, and education studies.

The database contains information on the trial's purpose, eligibility criteria, study design, location, sponsor, funding source, primary outcome measures, enrollment status, and estimated completion date. Additionally, it includes contact information for the trial's principal investigator(s), coordinator(s), and other relevant contacts.

To access the database, you can visit the website at https://clinicaltrials.gov/ and search for specific trials using keywords or filters such as trial type, disease, location, or sponsor.

InnoCare Pharma announced FDA approval for its Bcl-2 inhibitor, ICP-248, to enter clinical trials
Latest Hotspot
3 min read
InnoCare Pharma announced FDA approval for its Bcl-2 inhibitor, ICP-248, to enter clinical trials
22 January 2024
InnoCare Pharma has disclosed that the FDA has given approval to proceed with the clinical study for its BCL2 inhibitor, designated as ICP-248.
Read →
Exploring the Latest ADC Deal by Ambrx Biopharma: A Guide to Rapidly Accessing Transaction Insights
DrugDeal Decode
3 min read
Exploring the Latest ADC Deal by Ambrx Biopharma: A Guide to Rapidly Accessing Transaction Insights
22 January 2024
On January 8, 2024, Johnson & Johnson acquired Ambrx Biopharma for $2 billion to enhance its Antibody-Drug Conjugate (ADC) portfolio, including promising treatments like ARX517 for metastatic prostate cancer.
Read →
AM-Pharma Begins Stage 2 Clinical Study on Ilofotase Alfa for Renal Injury Linked to Heart Surgery Procedures
Latest Hotspot
3 min read
AM-Pharma Begins Stage 2 Clinical Study on Ilofotase Alfa for Renal Injury Linked to Heart Surgery Procedures
22 January 2024
AM-Pharma B.V. has started Phase 2 trials treating patients to test its enzyme, ilofotase alfa, for preventing kidney injury post-cardiac surgery.
Read →
Why was ClinicalTrials.gov created?
Knowledge Base
2 min read
Why was ClinicalTrials.gov created?
22 January 2024
ClinicalTrials.gov is a public database that contains information on clinical trials conducted around the world.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.